Skip to Main Content
LuminUltra
EnglishFrançais简体中文
two scientists in a lab in LuminUltra lab coats

LuminUltra submits COVID-19 clinical diagnostic testing kit for regulatory authorization

End-to-end solution and components offer flexibility to testing facilities, meeting high-volume demand and significantly boosting global testing capacity

FREDERICTON, NB, Sept. 14, 2020 – Canada-based biotechnology front-runner LuminUltra announced today that it has submitted its GeneCount® COVID-19 RT-qPCR Assay Kit (COVID-19 Assay) to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) and to Health Canada for an Interim Order (IO). With authorization to use this key testing component, LuminUltra, a leader in field-based molecular diagnostic testing for over 20 years, will provide a complete clinical COVID-19 testing solution that can be customized for testing facilities throughout North America.

LuminUltra’s accurate GeneCount® COVID-19 RT-qPCR Testing Solution comprises multiple components that together make up an end-to-end solution, including: sample collection kits; isolation reagents; the COVID-19 Assay; and a range of quick-detection qPCR testing devices with software for simple interpretation of COVID-19 test results in under two hours.

With the authorization of the COVID-19 Assay, LuminUltra will be able to offer flexibility to appropriate facilities around the world by providing some or all of the necessary COVID-19 testing components from a single, reputable company. This reduces the need to source components from multiple suppliers, allowing facilities to onboard additional testing capacity quickly. Underscoring its reliable supply chain, LuminUltra responded promptly to the Government of Canada’s testing needs earlier in the year, and has been a key supplier of the isolation reagents for the national testing program since April, providing 500,000 tests a week.

Facilities can select COVID-19 testing devices based on their respective requirements and size, from portable, qPCR testing devices that can assess up to 16 samples in under two hours period, to large format, high-capacity and automated qPCR and extraction devices.

“Human diagnostic testing for COVID-19 has scaled up very quickly and has become complicated for users. We hear frustration as facilities are forced to source inflexible components for testing from different companies and work through supply chain issues since these products are in high-demand – all while trying to provide safe testing solutions for patients,” said LuminUltra Chairman and CEO Pat Whalen. “We have been working relentlessly to provide flexible solutions that we are confident in – all from one company with a proven track record of meeting demand.”

LuminUltra has a history of biological testing innovation. Alongside the clinical diagnostic test, LuminUltra is also the creator of the GeneCount Environmental Monitoring Solutions – an on-site environment monitoring system that detects the presence of SARS-CoV-2, the virus that causes COVID-19, on surfaces, in the air, or in wastewater. This monitoring system, launched in May 2020, allows corporations, building managers, hotels, cruise ship operators, service providers and others to verify disinfection protocols as well as pinpoint potential asymptomatic and presymptomatic carriers within two hours. The GeneCount qPCR devices – both the portable and high-capacity options – can also run the environmental test, providing a holistic approach to pandemic management. The work done on research and development for the environmental test has helped to ensure a reliable and market-ready clinical test.

Assets, including images of the GeneCount qPCR product and application photos, can be found here.

About LuminUltra

Founded in 1995, LuminUltra is a biological diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring and is a key supplier of COVID-19 clinical testing reagents to the Government of Canada. Customers in over 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe-state. To learn more, visit luminultra.com/clinical

For further information:

Media Contact: Jessica Stutt, Director of Communications and Marketing, jessica.stutt@luminultra.com, +1-250-609-0215


LuminUltra Team

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and is a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Related Posts

[Radio Interview] Helping the Water Sector Solve Microbiological Problems in Water

  LuminUltra CEO Pat Whalen took part in an interview with Water Online Radio while attending the Annual Conference & Exposition of the American Water Works Association (AWWA’s ACE17) in Philadelphia. The discussion touched on a number of interesting topics that we thought might be of interest to you. You’ll find the interview excerpted below…. Read More

Flexibility is the key to stability
[Series 4/7]

  The genesis of LuminUltra was to construct an ATP-based test kit for quantifying biomass in wastewater treatment bioreactors.  This is where we focused our research efforts from the mid 90’s to the mid-2000’s, as well as the entirety of our commercial efforts from 2003-05.  Though we knew for certain that this would be a… Read More

Hurricane Irma: One for the Record Books

  Hurricanes are fantastically powerful events. Watching Hurricane Irma churn across the Northern Caribbean and up the west coast of Florida certainly puts the awesome power of wind and water into perspective. Storms like this one are devastating for the unfortunate people who find themselves in the way. One of the most damaging elements of… Read More

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now